Compare BCRX & AMPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCRX | AMPL |
|---|---|---|
| Founded | 1986 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.4B |
| IPO Year | 1995 | 2021 |
| Metric | BCRX | AMPL |
|---|---|---|
| Price | $8.40 | $7.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $20.82 | $13.50 |
| AVG Volume (30 Days) | ★ 4.1M | 2.7M |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | 11.84 |
| EPS | ★ 1.21 | N/A |
| Revenue | $25,186,000.00 | ★ $343,214,000.00 |
| Revenue This Year | N/A | $17.43 |
| Revenue Next Year | $12.55 | $14.16 |
| P/E Ratio | $7.02 | ★ N/A |
| Revenue Growth | N/A | ★ 14.68 |
| 52 Week Low | $6.00 | $6.00 |
| 52 Week High | $11.31 | $14.27 |
| Indicator | BCRX | AMPL |
|---|---|---|
| Relative Strength Index (RSI) | 61.61 | 42.86 |
| Support Level | $7.95 | $6.00 |
| Resistance Level | $8.68 | $7.74 |
| Average True Range (ATR) | 0.32 | 0.40 |
| MACD | 0.02 | 0.16 |
| Stochastic Oscillator | 64.31 | 57.93 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue primarily through selling subscriptions to the platform. The company derives a majority of its revenue from the United States.